| Nov 9 |
Spectral Medical Third Quarter 2024 Earnings: CA$0.035 loss per share (vs CA$0.012 loss in 3Q 2023)
|
| Nov 8 |
Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment
|
| Nov 8 |
Spectral Medical Announces Third Quarter Results and Provides Corporate Update
|
| Nov 4 |
Spectral Medical Provides October Tigris Trial Update
|
| Nov 1 |
Those who invested in Spectral Medical (TSE:EDT) three years ago are up 122%
|
| Oct 3 |
Spectral Medical Provides September Tigris Trial Update
|
| Sep 3 |
Spectral Medical Provides August Tigris Trial Update
|
| Aug 12 |
Spectral Medical’s revenue up 54% as company eyes Tigris trial completion
|
| Aug 12 |
Spectral Medical Second Quarter 2024 Earnings: CA$0.016 loss per share (vs CA$0.014 loss in 2Q 2023)
|
| Aug 9 |
Spectral Medical Announces Second Quarter Results and Provides Corporate Update
|
